 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Eloxx Pharmaceuticals Inc. (ELOX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-01-30 Exercise | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. CHIEF BUSINESS OFFICER | 6,250 | $0 | 6,250 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. CHIEF BUSINESS OFFICER | 2,045 | $3.91 | 4,205 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. CHIEF BUSINESS OFFICER | 6,250 | $0 | 18,750 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. COO | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. COO | 2,590 | $3.91 | 4,910 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. COO | 7,500 | $0 | 22,500 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:26 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 5,000 | $0 | 9,500 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-01-31 5:26 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 1,733 | $3.91 | 7,767 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:26 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 5,000 | $0 | 15,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-26 7:01 pm | N/A 2030-02-25 | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 200,000 | $0 | 200,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-26 7:01 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-26 7:03 pm | N/A 2030-02-25 | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 400,000 | $0 | 400,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-26 7:03 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 200,000 | $0 | 200,000 (Direct) | View |
| 2020-02-29 Exercise | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 76,806 | $0 | 267,552 (Direct) | View |
| 2020-02-29 Tax Withholding | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 23,285 | $3.13 | 244,267 (Direct) | View |
| 2020-02-29 Exercise | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 71,199 | $0 | 0 (Direct) | View |
| 2020-02-29 Exercise | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 5,607 | $0 | 0 (Direct) | View |
| 2020-02-29 Exercise | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. FORMER CHIEF BUSINESS OFFICER | 4,688 | $0 | 8,893 (Direct) | View |
| 2020-02-29 Tax Withholding | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. FORMER CHIEF BUSINESS OFFICER | 1,534 | $3.13 | 7,359 (Direct) | View |
| 2020-02-29 Exercise | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. FORMER CHIEF BUSINESS OFFICER | 4,688 | $0 | 0 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 5,000 | $0 | 9,500 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 1,733 | $3.91 | 7,767 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 5,000 | $0 | 15,000 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 2,590 | $3.91 | 4,910 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 7,500 | $0 | 22,500 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. FORMER CHIEF BUSINESS OFFICER | 6,250 | $0 | 6,250 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. FORMER CHIEF BUSINESS OFFICER | 2,045 | $3.91 | 4,205 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. FORMER CHIEF BUSINESS OFFICER | 6,250 | $0 | 18,750 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 6,250 | $0 | 6,250 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 2,166 | $3.91 | 4,084 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 6,250 | $0 | 18,750 (Direct) | View |
| 2020-03-15 Exercise | 2020-03-16 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 3,750 | $0 | 11,517 (Direct) | View |
| 2020-03-15 Tax Withholding | 2020-03-16 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 1,086 | $2.85 | 10,431 (Direct) | View |
| 2020-03-15 Exercise | 2020-03-16 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 3,750 | $0 | 0 (Direct) | View |
| 2020-04-30 Exercise | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,562 | $0 | 5,646 (Direct) | View |
| 2020-04-30 Tax Withholding | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 459 | $2.92 | 5,187 (Direct) | View |
| 2020-04-30 Exercise | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,562 | $0 | 17,188 (Direct) | View |
| 2020-04-30 Exercise | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 1,875 | $0 | 6,785 (Direct) | View |
| 2020-04-30 Tax Withholding | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 577 | $2.92 | 6,208 (Direct) | View |
| 2020-04-30 Exercise | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 1,875 | $0 | 20,625 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Kleijwegt Martijn Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Avnur Zafrira Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Veinrib Gadi Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax IV GP L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner | 20,000 | $0 | 20,000 (Indirect) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax IV GP L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner | 20,000 | $0 | 20,000 (Indirect) | View |
| 2020-05-20 Option Award | 2020-05-26 3:03 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-07-30 Exercise | 2020-07-31 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 1,875 | $0 | 8,083 (Direct) | View |
| 2020-07-30 Tax Withholding | 2020-07-31 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 576 | $2.84 | 7,507 (Direct) | View |
| 2020-07-30 Exercise | 2020-07-31 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 1,875 | $0 | 18,750 (Direct) | View |
| 2020-07-30 Exercise | 2020-07-31 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,563 | $0 | 6,750 (Direct) | View |
| 2020-07-30 Tax Withholding | 2020-07-31 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 459 | $2.84 | 6,291 (Direct) | View |
| 2020-07-30 Exercise | 2020-07-31 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,563 | $0 | 15,625 (Direct) | View |
| 2020-10-30 Exercise | 2020-11-02 4:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,562 | $0 | 7,853 (Direct) | View |
| 2020-10-30 Tax Withholding | 2020-11-02 4:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 459 | $2.53 | 7,394 (Direct) | View |
| 2020-10-30 Exercise | 2020-11-02 4:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,562 | $0 | 14,063 (Direct) | View |
| 2020-10-30 Exercise | 2020-11-02 4:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 1,875 | $0 | 9,382 (Direct) | View |
| 2020-10-30 Tax Withholding | 2020-11-02 4:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 625 | $2.53 | 8,757 (Direct) | View |
| 2020-10-30 Exercise | 2020-11-02 4:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 1,875 | $0 | 16,875 (Direct) | View |
| 2021-01-30 Exercise | 2021-02-02 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 1,875 | $0 | 10,632 (Direct) | View |
| 2021-01-30 Tax Withholding | 2021-02-02 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 643 | $3.44 | 9,989 (Direct) | View |
| 2021-01-30 Exercise | 2021-02-02 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 1,875 | $0 | 15,000 (Direct) | View |
| 2021-01-30 Exercise | 2021-02-02 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,563 | $0 | 8,957 (Direct) | View |
| 2021-01-30 Tax Withholding | 2021-02-02 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 542 | $3.44 | 8,415 (Direct) | View |
| 2021-01-30 Exercise | 2021-02-02 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,563 | $0 | 12,500 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-17 6:38 pm | N/A 2031-02-12 | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-17 6:40 pm | N/A 2031-02-12 | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-17 6:43 pm | N/A 2031-02-12 | Eloxx Pharmaceuticals Inc. | ELOX | MacDonald Stephen G. VP | 18,849 | $0 | 18,849 (Direct) | View |
| 2021-02-25 Exercise | 2021-02-26 7:05 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 50,000 | $0 | 59,989 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-02-26 7:05 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 15,360 | $3.95 | 44,629 (Direct) | View |
| 2021-02-25 Exercise | 2021-02-26 7:05 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 50,000 | $0 | 150,000 (Direct) | View |
| 2021-02-25 Exercise | 2021-02-26 7:05 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 25,000 | $0 | 33,415 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-02-26 7:05 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 7,338 | $3.95 | 26,077 (Direct) | View |
| 2021-02-25 Exercise | 2021-02-26 7:05 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 25,000 | $0 | 75,000 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 8:55 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit CEO | 223,304 | $0 | 223,304 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 8:55 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit CEO | 55,854 | $0 | 279,158 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 8:55 pm | N/A 2031-04-01 | Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit CEO | 1,423,238 | $0 | 1,423,238 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 9:00 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R&D | 174,643 | $0 | 174,643 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 9:00 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R&D | 44,683 | $0 | 219,326 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 9:00 pm | N/A 2031-04-01 | Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R&D | 711,619 | $0 | 711,619 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 9:04 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Walts Alan Edmund Director | 37,695 | $0 | 37,695 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 9:04 pm | N/A 2031-04-01 | Eloxx Pharmaceuticals Inc. | ELOX | Walts Alan Edmund Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-05 8:33 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director | 87,031 | $0 | 87,031 (Indirect) | View |
| 2021-04-01 Option Award | 2021-04-05 8:33 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director | 2,445,239 | $0 | 2,445,239 (Indirect) | View |
| 2021-04-01 Option Award | 2021-04-05 8:33 pm | N/A 2031-04-01 | Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-04-20 Option Award | 2021-04-22 11:55 am | N/A 2026-04-20 | Eloxx Pharmaceuticals Inc. | ELOX | Geffken Daniel E. CFO | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-04-30 Exercise | 2021-05-03 10:15 am | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,562 | $0 | 27,639 (Direct) | View |
| 2021-04-30 Tax Withholding | 2021-05-03 10:15 am | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 459 | $2.18 | 27,180 (Direct) | View |
| 2021-04-30 Exercise | 2021-05-03 10:15 am | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,562 | $0 | 10,938 (Direct) | View |